Maitake for Integrative Cancer Care
Launched by THE CANADIAN COLLEGE OF NATUROPATHIC MEDICINE · Mar 14, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Maitake for Integrative Cancer Care," is studying the effects of Maitake, an edible mushroom, on the immune system of people undergoing cancer treatment. Researchers want to find out if adding Maitake to standard cancer therapies, like chemotherapy, can help boost the immune response in patients. The trial is currently recruiting participants in Ontario, Canada, and is open to adults aged 18 and older who have been diagnosed with cancer and are receiving specific types of cancer treatment.
To be eligible for the trial, participants must not have certain blood cancers or allergies to mushrooms, and they should not have taken any mushroom supplements in the last six months. Those who are managing diabetes or taking certain medications will also be excluded from the study. If you join the trial, you can expect to receive Maitake alongside your regular cancer treatment, and you will need to attend in-person visits in Ottawa or Toronto. This study could provide valuable information about the potential benefits of Maitake for cancer patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults (≥18 years of age)
- • 2. Confirmed cancer diagnosis through biopsy or radiologic imaging
- • 3. Undergoing systemic treatment with either chemotherapy or CD4/6 inhibitors
- • 4. Currently receiving cancer treatment in Ontario, Canada
- Exclusion Criteria:
- • 1. Hematologic cancers
- • 2. Previously received any mushroom supplement within 6 months prior to enrolment
- • 3. Allergy to mushrooms or mushroom products
- • 4. Diagnosis of diabetes
- • 5. Currently taking hypoglycemic or anticoagulant medications
- • 6. Currently receiving immune checkpoint inhibitors
- • 7. Unable to attend in in-person visits in either Ottawa or Toronto
- • 8. Any reason which, under the discretion of the Qualified Investigator or delegate, would preclude the patient from participating
About The Canadian College Of Naturopathic Medicine
The Canadian College of Naturopathic Medicine (CCNM) is a leading institution dedicated to advancing the field of naturopathic medicine through education, research, and clinical practice. As a prominent clinical trial sponsor, CCNM focuses on the rigorous investigation of naturopathic therapies and their efficacy in promoting health and wellness. By fostering a collaborative environment, CCNM engages with healthcare professionals, researchers, and the community to support innovative clinical research initiatives and contribute to the evidence base of complementary and alternative medicine. Through its commitment to high ethical standards and scientific integrity, CCNM aims to enhance the understanding and application of naturopathic care within the broader healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ottawa, Ontario, Canada
Toronto, Ontario, Canada
Patients applied
Trial Officials
Adrienne Junek, MD
Principal Investigator
Centre for Health Innovation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported